about
Serum bactericidal assays to evaluate typhoidal and nontyphoidal Salmonella vaccines.Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates.Strategies for Coordination of a Serosurvey in Parallel with an Immunization Coverage Survey.Shigella IpaB and IpaD displayed on L. lactis bacterium-like particles induce protective immunity in adult and infant mice.Functional Activity of Antibodies Directed towards Flagellin Proteins of Non-Typhoidal Salmonella.Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD.Safety and immunogenicity of a single oral dose of recombinant double mutant heat-labile toxin derived from enterotoxigenic Escherichia coli.Live Attenuated Human Salmonella Vaccine Candidates: Tracking the Pathogen in Natural Infection and Stimulation of Host ImmunityAge-dependent association among Helicobacter pylori infection, serum pepsinogen levels and immune response of children to live oral cholera vaccine CVD 103-HgRSafety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks.A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions.A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infectionBioactive Immune Components of Anti-Diarrheagenic Enterotoxigenic Escherichia coli Hyperimmune Bovine Colostrum Products.Human immune responses against Shigella and enterotoxigenic E. coli: Current advances and the path forward.Simple method for purification of enterotoxigenic Escherichia coli fimbriaeSpringtime for CVI.Enterotoxigenic Escherichia coli is phagocytosed by macrophages underlying villus-like intestinal epithelial cells: modeling ex vivo innate immune defenses of the human gut.Safety and Immunogenicity of a Single Oral Dose of Recombinant Double Mutant Heat-Labile Toxin Derived from Enterotoxigenic Escherichia coli.Immunogenicity and efficacy following sequential parenterally-administered doses of Salmonella Enteritidis COPS:FliC glycoconjugates in infant and adult mice.Development, Interlaboratory Evaluations, and Application of a Simple, High-Throughput Shigella Serum Bactericidal Assay.A Novel Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental ChallengemSphere of Influence: the View from the Microbiologists of the Future.Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial resultsFunctional antibodies as immunological endpoints to evaluate protective immunity against ShigellaA Combined YopB and LcrV Subunit Vaccine Elicits Protective Immunity against Yersinia Infection in Adult and Infant MicePregnancy level of estradiol attenuated virus-specific humoral immune response in H5N1-infected female mice despite inducing anti-inflammatory protection
P50
Q33601858-51726F2A-2F1B-4ACF-9512-367C090C98FCQ34760675-D3BB8900-1BE2-4C41-9757-7DBD2E8347E8Q35934056-58AC3F5A-2053-41FA-8AA0-6DC36C0C5F15Q35946462-751A02EC-6B2B-409C-BE4B-3A53BE8D5A34Q35964671-30362AFA-BA58-4DC0-91C8-67554D56B041Q37032264-3EB2BC7B-16DB-4EFE-9C68-C9C036E7853EQ37335500-4190235E-49F4-4809-A767-E0CD9B163C82Q37429384-A65D4648-3C05-4C91-9D22-3834C7BE90D5Q37483766-55274BC9-3544-4FA7-A188-FA6D05A5D694Q37544964-996E0A36-22B1-43B0-9EA7-295CEA52E451Q37721649-DF3C35BC-D86B-4CF4-BCFD-5F6967CCAAF9Q39015820-79A94578-5718-436D-819F-60D00500CEB9Q40163181-3D74318A-0D40-4F85-BB61-53FA056EAF2EQ40192692-5BFC1350-022E-4F42-9A0D-6327BF169A83Q40905058-48E6C3F5-2537-4D15-9EE0-A562975D98F9Q42918016-0027541B-D1F7-4BDD-8BF6-54FA2CE6F6EAQ45071462-B3BA5949-93C8-4547-A319-205B6223F10CQ46607652-04C35293-BC4D-4D50-B239-ADBB9098A158Q54201279-56791298-5F60-472B-826E-F0E033D14F1FQ55333715-A7C87AA7-2298-40C4-B23D-D11CA7C3C95DQ57929967-DF70CFF8-4760-4F93-95D2-A1433C07B299Q64981497-2748B2E4-701C-4F6C-8E8B-C202EC2BA6D5Q87747419-3A104D2D-045B-4248-8C68-31F745059B34Q91741853-3898EABB-9687-4663-B4E5-48299ED787B1Q91760327-D7A58412-6806-4D35-834B-938C1E28D8D8Q92308204-CDC263DD-C7E0-4E9B-AA58-922CF4BBE435
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marcela F Pasetti
@ast
Marcela F Pasetti
@en
Marcela F Pasetti
@es
Marcela F Pasetti
@nl
Marcela F Pasetti
@sl
type
label
Marcela F Pasetti
@ast
Marcela F Pasetti
@en
Marcela F Pasetti
@es
Marcela F Pasetti
@nl
Marcela F Pasetti
@sl
prefLabel
Marcela F Pasetti
@ast
Marcela F Pasetti
@en
Marcela F Pasetti
@es
Marcela F Pasetti
@nl
Marcela F Pasetti
@sl
P106
P21
P31
P496
0000-0003-0894-4009